Does vitamin B12 deficiency cause macrocytosis with leukopenia and neutropenia?

Vitamin B12 deficiency is a well-established cause of significant hematologic abnormalities due to its essential role in DNA synthesis. This deficiency leads to a systemic impairment of cellular maturation, particularly affecting the rapidly dividing cells within the bone marrow.

Clinical and effectiveness evidence

The clinical presentation of Vitamin B12 deficiency frequently includes macrocytic anemia and, in more advanced cases, pancytopenia (a reduction in all three blood cell lines).

• Macrocytosis: Research shows that deficiency results in a mean corpuscular volume (MCV) typically exceeding 100 fL. This is a hallmark sign of megaloblastic anemia, where red blood cells are abnormally large.
• Leukopenia and Neutropenia: Ineffective hematopoiesis is not limited to red blood cells; it also affects white blood cell production. Studies indicate that approximately 5% of unexplained neutropenia cases in some cohorts may be attributable to B12 deficiency. Neutropenia specifically results from maturation arrest at the promyelocyte or myelocyte stage.
• Recovery: Hematologic markers generally show rapid improvement with supplementation, with white blood cell counts typically normalizing within 1 to 2 weeks of starting B12 therapy.

Mechanistic explanations

The underlying cause of these blood disorders is the disruption of the "folate trap" and the subsequent failure of DNA replication.

• DNA Synthesis Failure: Vitamin B12 is a mandatory cofactor for the enzyme methionine synthase. Without it, 5-methyltetrahydrofolate cannot be converted back into tetrahydrofolate (THF). This sequestration of folate prevents the synthesis of thymidine (dTMP), a necessary building block for DNA.
• Nuclear-Cytoplasmic Asynchrony: Because DNA synthesis is stalled while RNA and protein synthesis continue, the cell's nucleus matures much more slowly than its cytoplasm. This results in "megaloblastic" changes—large, immature-looking nuclei in large cells.
• Intramedullary Apoptosis: These malformed hematopoietic precursors are fragile and often undergo programmed cell death (apoptosis) or destruction within the bone marrow before they can enter the bloodstream. This process, known as ineffective hematopoiesis, explains why a hypercellular bone marrow can still result in low peripheral blood counts (cytopenias).

Bottom line

Vitamin B12 deficiency causes ineffective hematopoiesis by arresting DNA synthesis, leading to macrocytosis and, frequently, leukopenia and neutropenia due to the intramedullary destruction of white blood cell precursors.